Article
TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
The Laryngoscope - 1 Jul 2014
Heaton Chase M, Durr Megan L, Tetsu Osamu, van Zante Annemieke, Wang Steven J
Abstract excerpt
OBJECTIVES/HYPOTHESIS: To determine the incidence and clinical significance of TP53 and CDKN2a somatic mutations in never smokers with oral tongue squamous cell carcinoma (OTSCC). STUDY DESIGN: Case series. METHODS: Fifty-one paraffin-embedded tumors from never smokers with OTSCC were obtained. p53 and p16 expression was determined by immunohistochemical (IHC) staining. Tumor DNA was amplified by polymerase chain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
